Patent ID: 8003798

Claim:
A compound of formula I in which R1 is methoxy or ethoxy, R2 is methoxy, ethoxy, 2,2-difluoroethoxy or difluoromethoxy, R3 is hydrogen, R31 is hydrogen, R4 is —O—R41, in which R41 is hydrogen or acetyl, and R5 is hydrogen, and Har is Cyc1, in which Cyc1 is benzo[1,3]dioxol-5-yl, dihydrobenzo[1,4]dioxin-5-yl, 2,2-difluoro-benzo[1,3]dioxol-5-yl, or 5-chloro-4-methyl-3,4-dihydrobenzo[1,4]oxazin-7-yl, or Har is Cyc2, in which Cyc2 is quinolin-6-yl, benzofurazan-5-yl, benzothiazol-6-yl, 1-methyl-1H-benzotriazol-5-yl or 4-methoxy-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-5-yl, benzo[1,2,3] thiadiazol-5-yl or quinoxalin-5-yl, or, Har is optionally substituted by R6 and/or R7 and/or R8, and is a pyridinyl, pyrimidinyl, pyrazinyl or pyridazinyl radical, in which R6 is chlorine, methyl, methoxy, ethoxy, methylthio, methoxycarbonyl, carboxyl, hydroxyl, oxo, or -A-N(R61)R62, in which A is a bond or ethylene, R61 is methyl, R62 is methyl, or R61 and R62 together and with inclusion of the nitrogen atom, to which they are attached, form a heterocyclic ring Het1, in which either Het1 is piperidin-1-yl, pyrrolidin-1-yl or morpholin-4-yl, or Het1 is pyrazol-1-yl or imidazol-1-yl, R7 is methyl, methoxy, ethoxy, methylthio or dimethylamino, R8 is chlorine or methoxy, or Har is isoxazolyl, 1-methylimidazolyl, or pyridyl-thiazolyl, or a salt, enantiomer, N-oxide, salt of an N-oxide or enantiomer thereof.